Boiron

Sanofi-aventis is a division of its namesake European parent company, which is one of the world s largest pharmaceutical companies. Backed by a world-class research and development organization, the company develops leading positions in nearly 10 major therapeutic areas that include cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines. The Sanofi-aventis group employs approximately 14,000 employees in the United States located at nearly 15 geographical sites throughout the country. Of these, approximately 8,000 are field sales and medical affairs representatives, making the company s sales force one of the largest in the U.S. pharmaceutical industry. Some of its products include Actonel, Allegra, Ambien, Eloxatin, Nasacort, Plavix, Taxotere and Uroxatral. Sanofi-aventis maintains a location in Bridgewater, N.J.

CSL Behring is one of the leading providers of plasma protein biotherapeutic products in the world. It is a pharmaceutical company engaged in the research and development of life-saving biotherapies for the treatment of coagulation disorders, such as hemophilia and von Willebrand diseases. The company additionally manufactures a variety of medicines and drugs for the treatment of immune deficiencies, genetic emphysema, sepsis, severe burns, wounds and heomolytic diseases. It also provides medicines for transplantation, coagulation, immunology and critical care applications. The company supplies products under the Cytogam, Helixate, Humate-P, Monoclate-P, Mononine, Stimate, AlbuRx, Albuminar and Vivaglobin brands. It offers sales, marketing, distribution, online ordering and customer support services. The company maintains CSL Plasma, which is a plasma collection network that operates throughout the United States and Germany. CSL Behring is a part of CSL Limited, which is an Australia-based company that supplies sera and vaccines.

AmerisourceBergen is one of the nation's largest pharmaceutical services providers. The company provides branded pharmaceuticals, generic pharmaceuticals, biotech and specialty drugs, over-the-counter remedies and health and beauty aids to independent retail pharmacies, national and regional chains, hospitals, clinics, pharmacy benefit managers, prescription mail order facilities, physician offices and long-term care facilities. AmerisourceBergen operates in two segments: pharmaceutical distribution, which includes the operations of AmerisourceBergen Drug Corporation, Specialty Group and Packaging Group; and PharMerica, which includes the long-term care pharmacy and workers' compensation businesses. The company has more than 14,000 employees. AmerisourceBergen began operations in August of 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. It is one of the largest pharmaceuticals distributors in the United States and has its headquarters in Valley Forge, Pa., and a Western management center in Orange, Calif. R. David Yost has been the chief executive officer of AmerisourceBergen for more than nine years. He has been with the medical and health care company for over 32 years. Yost earned a BS degree from the United States Air Force Academy, and a MBA from the University of California-Los Angeles. AmerisourceBergen has 43 distribution centers providing daily delivery in the United States.